Figure 2.
Figure 2. Expansion of CD94/NKG2C+ cells in PBLs from HCMV-positive donors. Blood donors were classified in 2 groups (HCMV-positive and HCMV-negative) according to the detection of circulating HCMV-specific IgG; PBL samples were analyzed as described (Figure 1). (A-B) The proportions of NKG2A+ (Z199+) and NKG2C+ (p25+Z199-) cells detected in total PBLs, as well as in gated CD3+ and CD3- subsets, from 68 different individuals are shown (mean ± SEM). (C) The percentage of NK cells (CD3-CD56+) expressing NKG2A or NKG2C in PBLs from 21 HCMV-positive and HCMV-negative donors are displayed (mean ± SEM). Statistical analysis was carried out as described in “Patients, materials, and methods”; ***P < .001.

Expansion of CD94/NKG2C+ cells in PBLs from HCMV-positive donors. Blood donors were classified in 2 groups (HCMV-positive and HCMV-negative) according to the detection of circulating HCMV-specific IgG; PBL samples were analyzed as described (Figure 1). (A-B) The proportions of NKG2A+ (Z199+) and NKG2C+ (p25+Z199-) cells detected in total PBLs, as well as in gated CD3+ and CD3- subsets, from 68 different individuals are shown (mean ± SEM). (C) The percentage of NK cells (CD3-CD56+) expressing NKG2A or NKG2C in PBLs from 21 HCMV-positive and HCMV-negative donors are displayed (mean ± SEM). Statistical analysis was carried out as described in “Patients, materials, and methods”; ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal